Daxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions

Stock Information for Daxor Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Daxor Corporation

Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.